Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Protara Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +4 vs. Q4 2023
- Shares held
- 4.57M
- +212.5K (+4.9%) vs. Q4 2023
- Total value
- $18.3M
- +$10.2M (+124.6%) vs. Q4 2023
- New holders
- 7
- 8 more added
- Sold out
- 3
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $10.8M | 2.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 427,612 | $1.71M | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $839.0K | 0.04% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 202,701 | $812.8K | 0.22% | +14,037+7.4% | Added |
| Baker Bros. Advisors LP | 199,671 | $800.7K | 0.01% | 00.0% | Unchanged |
| StemPoint Capital LP | 168,442 | $675.5K | 0.18% | +168,442 | New |
| Privium Fund Management (UK) Ltd | 119,730 | $495.7K | 0.25% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 84,600 | $339.0K | 0.00% | −28,700−25.3% | Reduced |
| Geode Capital Management, LLC | 82,907 | $332.5K | 0.00% | +4,389+5.6% | Added |
| Bridgeway Capital Management, LLC | 59,000 | $236.6K | 0.00% | −5,000−7.8% | Reduced |
| BlackRock Inc. | 30,864 | $123.8K | 0.00% | −3,452−10.1% | Reduced |
| LPL Financial LLC | 28,000 | $112.3K | 0.00% | +16,000+133.3% | Added |
| Two Sigma Advisers, LP | 27,018 | $108.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,600 | $106.7K | 0.00% | −4,300−13.9% | Reduced |
| Citadel Advisors LLC | 25,948 | $104.1K | 0.00% | −12,087−31.8% | Reduced |
| Boothbay Fund Management, LLC | 22,647 | $90.8K | 0.00% | +3,783+20.1% | Added |
| Truist Financial Corp | 20,000 | $80.2K | 0.00% | +20,000 | New |
| Two Sigma Investments, LP | 19,748 | $79.2K | 0.00% | −5,397−21.5% | Reduced |
| Bank of New York Mellon Corp | 17,907 | $71.8K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 17,850 | $71.0K | 0.00% | +17,850 | New |
| Northern Trust Corp | 17,591 | $70.5K | 0.00% | −536−3.0% | Reduced |
| Two Sigma Securities, LLC | 17,393 | $69.7K | 0.00% | +17,393 | New |
| Dimensional Fund Advisors LP | 12,126 | $48.6K | 0.00% | +12,126 | New |
| Susquehanna International Group, LLP | 11,185 | $44.9K | 0.00% | +11,185 | New |
| Oppenheimer & Co Inc | 10,000 | $40.1K | 0.00% | +10,000 | New |
| Acadian Asset Management LLC | 6,314 | $25.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,986 | $16.0K | 0.00% | +3,258+447.5% | Added |
| UBS Group AG | 3,725 | $14.9K | 0.00% | +2,809+306.7% | Added |
| Tower Research Capital LLC (TRC) | 2,580 | $10.3K | 0.00% | −1,758−40.5% | Reduced |
| ADAR1 Capital Management, LLC | 2,000 | $8.02K | 0.00% | −194−8.8% | Reduced |
| Wells Fargo & Company | 570 | $2.29K | 0.00% | +1+0.2% | Added |
| Advisor Group Holdings, Inc. | 100 | $401 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 22 | $88 | 0.00% | +6+37.5% | Added |
| Qube Research & Technologies Ltd | 2 | $8 | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −15,831−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,506−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |